Vir Biotechnology, Inc. Common Stock (NASDAQ: VIR) last traded at $9.78, up 6.19% on the session. The quote above updates while this page is open; the figures below are drawn from Vir Biotechnology, Inc. Common Stock’s own filings and are restated only when a new one is published.
Vir Biotechnology, Inc. Common Stock trades on NASDAQ under the ticker VIR. Its market capitalisation is $1.65 billion.
Valuation measures for Vir Biotechnology, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $1.65B |
|---|---|
| Enterprise value | $1.61B |
| Price / sales | 5.46 |
| Price / book | 1.68 |
| Beta | 1.76 |
Trailing-twelve-month figures tagged in Vir Biotechnology, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $303.23M |
|---|---|
| Net income (TTM) | -$251.68M |
| EPS (TTM) | -$1.86 |
| Operating margin | -92.40% |
| Return on equity | -25.62% |
| Cash | $278.73M |
Range and volume for VIR over the past 52 weeks.
| 52-week high | $11.66 |
|---|---|
| 52-week low | $4.35 |
| Volume | 1.73M |
| Average volume | 1.83M |
| Previous close | $9.21 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.